Coronavirus company news summary – Hong Kong and Macao suspend BioNTech Covid-19 vaccination after packaging flaw – Clover and Dynavax dose first patients in Phase II/III SPECTRA vaccine trial


Source: pharmaceutical-technology.com pharmaceutical-technology.com

Key Topics in this News Article:

News Snapshot:

Coronavirus company news summary – Hong Kong and Macao suspend BioNTech Covid-19 vaccination after packaging flaw – Clover and Dynavax dose first patients in Phase II/III SPECTRA vaccine trial 25 25th, 2021 10:16) Share Article Fosun Pharma , BioNTech’s partner in the development and distribution of the Comirnaty Covid-19 vaccine in greater China, have notified Hong Kong and Macao of a packaging flaw in batch 210102 of the vaccine. Shares of China’s Shanghai Fosun Pharmaceutical Group fell 5% after the cities suspended BioNTech vaccinations as a precautionary measure. The cities stated that the German vaccine maker and Fosun are currently...